Tanja Schmidt

Dr. Tanja Schmidt is an attorney-at-law specializing in domestic and international commercial litigation, and in particular financial and banking disputes. She clerked at the Swiss Federal Supreme Court in the field of law of obligations, before joining a leading business law firm as an associate.

Dr. Tanja Schmidt earned a PhD from the University of Geneva with a thesis on contract law. She also conducted research as a visiting scholar at Columbia Law School and at Max Planck Institute for Comparative and International Private Law.

Warning to buyers: non-disclosure of FDA warning letters in due diligence did not trigger sellers’ liability

Insufficient substantiation of claims by the buyer of shares of a homeopathic drugs company for damages caused by an alleged breach of contractual warranty (non-disclosure of FDA warning letters) in a share purchase agreement.